Skip to main content

Table 1 Baseline Characteristics of Study Population in Relation to Stroke Severity According to mRS Score at discharge

From: Is elevated SUA associated with a worse outcome in young Chinese patients with acute cerebral ischemic stroke?

Characteristic

MRS 0-2

(n = 426)

MRS 3-6

(n = 159)

P

Male/Female

283/143

107/52

0.844

Age, y

39.6 ± 6.5

39.2 ± 6.5

0.504

Current cigarette smoking, n (%)

120 (28.2%)

48 (30.2%)

0.631

Current Alcohol drinking, n (%)

78 (18.3%)

30 (18.9%)

0.877

Previous stroke/TIA, n (%)

56 (13.1%)

9 (5.7%)

0.010

Atrial fibrillation, n (%)

14 (3.3%)

24 (15.1%)

0.000

Hypertention, n (%)

190 (44.6%)

76 (47.8%)

0.49

Diabetes at baseline, n (%)

70 (16.4%)

43 (27.0%)

0.004

Hypercholesterolemia, n (%)

137 (32.2%)

41 (257%)

0.136

Hypertriglyceridemia, n (%)

161 (37.8%)

43 (27.0%)

0.015

Metabolic syndrome presence, n (%)

21 (4.9%)

10 (6.3%)

0.003

Family history of stroke, n (%)

19 (4.5%)

13 (8.2%)

0.079

Moyamoya/Cerebral vascular malformation, n (%)

14 (3.3%)

13 (8.2%)

0.012

TOAST classification

  

0.000

a. Large artery, n (%)

127 (29.8%)

84 (52.8%)

 

b. Small artery, n (%)

226 (53.1%)

19 (12.0%)

 

c. Cardioembolism, n (%)

21 (4.9%)

31 (19.5%)

 

d. Other cause, n (%)

52 (12.2%)

25 (15.7%)

 

nonfasting glucose, mmol/L

5.65 ± 2.44

6.44 ± 3.03

0.001

Platelet distribution width, fL

12.7 ± 4.6

12.1 ± 3.0

0.072

Platelet count, ×109/L

237.8 ± 80.0

224.9 ± 82.9

0.019

White cell count, ×109/L

8.6 ± 5.6

10.0 ± 4.2

0.000

Mean platelet volume, fl

10.2 ± 1.4

10.2 ± 1.5

0.85

UA, mmol/L

326.2 ± 103.4

295.7 ± 111.2

0.002

Triglyceride (TG), mmol/L

1.7 ± 1.4

1.6 ± 1.6

0.382

Cholesterol (CHOL), mmol/L

4.7 ± 1.1

4.9 ± 1.1

0.017

Fibrinogen, g/l

1.7 ± 0.4

2.7 ± 1.7

0.000